Rockefeller Capital Management L.P. Shockwave Medical, Inc. Transaction History

Rockefeller Capital Management L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$191.17 - $325.63 $472,189 - $804,306	-2,470 Reduced 13.59%	15,702 $5.11 Million
Q4 2023 Feb 14, 2024	BUY	$160.99 - $215.69 $2.93 Million - $3.92 Million	18,172 New	18,172 $3.46 Million
Q1 2023 May 17, 2023	BUY	$175.41 - $217.92 $363,098 - $451,094	2,070 Added 214.95%	3,033 $656,000
Q4 2022 Mar 06, 2023	SELL	$204.38 - $296.82 $7,766 - $11,279	-38 Reduced 3.8%	963 $197,000
Q3 2022 Nov 02, 2022	BUY	$195.21 - $310.53 $171,589 - $272,955	879 Added 720.49%	1,001 $278,000
Q2 2022 Aug 12, 2022	BUY	$115.91 - $214.48 $2,318 - $4,289	20 Added 19.61%	122 $23,000
Q1 2022 May 13, 2022	SELL	$127.96 - $207.36 $8,189 - $13,271	-64 Reduced 38.55%	102 $21,000
Q4 2021 Feb 14, 2022	BUY	$165.13 - $241.83 $14,036 - $20,555	85 Added 104.94%	166 $29,000
Q2 2021 Aug 10, 2021	BUY	$131.45 - $201.49 $1,577 - $2,417	12 Added 17.39%	81 $15,000
Q1 2021 May 11, 2021	BUY	$92.73 - $142.05 $5,285 - $8,096	57 Added 475.0%	69 $8,000
Q4 2020 Feb 12, 2021	BUY	$67.44 - $103.72 $809 - $1,244	12 New	12 $1,000

319K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.